Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 10-2018 | 07-2018 | 04-2018 | 01-2018 | 10-2017 | |
| Sales | 876 | 50,511 | 5,327 | -23,633 | 2,294 |
| Gross Profit | 876 | 50,511 | 5,327 | -23,633 | 2,294 |
| Operating Expenses | 13,012 | 12,611 | 14,394 | 9,754 | 10,402 |
| Operating Income | -12,136 | 37,900 | -9,067 | -33,387 | -8,108 |
| Interest Expense | 64 | 186 | 259 | 1,006 | 299 |
| Other Income | 0 | -1,598 | 1 | 5,626 | 4,098 |
| Pre-tax Income | -12,200 | 36,115 | -9,325 | -28,767 | -4,309 |
| Income Tax | -1,654 | 653 | -1,301 | -2,594 | -1,957 |
| Net Income Continuous | -10,545 | 35,462 | -8,024 | -26,173 | -2,352 |
| Net Income | $-10,545 | $35,462 | $-8,024 | $-26,173 | $-2,352 |
| EPS Basic Total Ops | -0.65 | 2.13 | -0.55 | -1.63 | -0.20 |
| EPS Basic Continuous Ops | -0.64 | 2.16 | -0.52 | -1.71 | -0.18 |
| EPS Diluted Total Ops | -0.65 | 2.13 | -0.55 | -1.63 | -0.20 |
| EPS Diluted Continuous Ops | -0.64 | 2.15 | -0.52 | -1.69 | -0.18 |
| EBITDA(a) | $-11,027 | $38,269 | $-9,784 | $-33,828 | $-7,976 |